Clinical trial
Clinical Phase I and IIa Trials of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss
NCT07404709 is registered in ClinicalTrials.gov with The Affiliated Hospital of Qingdao University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Phase I and IIa Trials of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss
- Lead sponsor
- The Affiliated Hospital of Qingdao University
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- February 28, 2026
- Completion date
- December 31, 2028
- Enrollment
- 9 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
extracellular vesicles, sudden hearing loss